Evaxion A (EVAX) Cash from Restructuring (2021)
Evaxion A's Cash from Restructuring was -$2.34 million in FY2024, compared with -$432,000 in FY2023.
Powered by 
Analysis
Evaxion A (EVAX) Cash from Restructuring (2021) Analysis & Trends
From FY2019 onward, Evaxion A has reported Cash from Restructuring for 5 years.
- The FY2024 figure marks the lowest annual Cash from Restructuring since FY2021.
- Per Business Quant data, Cash from Restructuring in earlier years was -$432,000 in FY2023, -$3.76 million in FY2021 and -$128,000 in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Evaxion A | 20.76 Mn | -45.48 Mn | - |
API Access
Evaxion A Cash from Restructuring API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=EVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-restructuring", "ticker": "EVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=EVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();